HomeMy WebLinkAbout20240123.tiffRESOLUTION
RE: APPROVE COOPERATION AGREEMENT FOR PAYMENT OF OPIOID SETTLEMENT
FUNDS FOR SUBSTANCE ABUSE PREVENTION AND AUTHORIZE CHAIR TO SIGN
AND SUBMIT ELECTRONICALLY - WELD OPIOID REGIONAL COUNCIL
WHEREAS, the Board of County Commissioners of Weld County, Colorado, pursuant to
Colorado statute and the Weld County Home Rule Charter, is vested with the authority of
administering the affairs of Weld County, Colorado, and
WHEREAS, the Board has been presented with a Cooperation Agreement for the
Payment of Opioid Settlement Funds for Substance Abuse Prevention between the County of
Weld, State of Colorado, by and through the Board of County Commissioners of Weld County, on
behalf of the Department of Public Health and Environment, and the Weld Opioid Regional
Council, commencing January 1, 2024, and ending December 31, 2024, with further terms and
conditions being as stated in said agreement, and
WHEREAS, after review, the Board deems it advisable to approve said agreement, a copy
of which is attached hereto and incorporated herein by reference.
NOW, THEREFORE, BE IT RESOLVED by the Board of County Commissioners of
Weld County, Colorado, that the Cooperation Agreement for the Payment of Opioid Settlement
Funds for Substance Abuse Prevention between the County of Weld, State of Colorado, by and
through the Board of County Commissioners of Weld County, on behalf of the Department of
Public Health and Environment, and the Weld Opioid Regional Council, be, and hereby is,
approved.
BE IT FURTHER RESOLVED by the Board that the Chair be, and hereby is, authorized
to electronically sign and submit said agreement.
The above and foregoing Resolution was, on motion duly made and seconded, adopted
by the following vote on the 17th day of January, A.D., 2024, nunc pro tunc January 1, 2024.
BOARD OF COUNTY COMMISSIONERS
WELD COUNTY
ATTEST: dit44) „e,/ ;vi
Weld County Clerk to the Board
APP
)1)1,1,6 c/ I (-
Deputy Clerk to the Board
Coun orney
Date of signature: _
a
Kevin oss, Chair
Perry L. Buclk(Pro-Tem
Mike F -eman
ames
cc•, CR(%)
°9./,20/2`1
2024-0123
HL0057
Contva c-i- ottn4?.
BOARD OF COUNTY COMMISSIONERS
PASS -AROUND REVIEW
PASS -AROUND TITLE: Opioid Council Cooperation Agreement Funding for Substance Use Prevention
Position
DEPARTMENT: Public Health & Environment DATE: January 3, 2024
PERSON REQUESTING: Jason Chessher, Executive Director
Eric Aakko, HECP Division Director
Brief description of the problem/issue:
Weld County is a member of the Opioid Regional Council (Region 3). The Council receives funding annually
from the Colorado Opioid Abatement Council (COAC), which is part of the national opioid settlement. The
Department of Public Health & Environment has been awarded $145,000 for FY 2024 to fund a full-time
Substance Use Disorder (SUD) prevention health educator. This funding is anticipated to continue for the next
15+ years.
What options exist for the Board?
Approving this funding from the Council will enable the substance abuse prevention work to continue in Weld
County. No new positions will be created as the opioid funding will be utilized to fund an existing position (this
is the second year of funding from the Council).
If the BOCC declines funding the position will be eliminated and the County will discontinue substance abuse
education efforts.
Consequences: Funding the health educator position will ensure alcohol, marijuana, and opioid use
prevention work continues in schools and the broader community of Weld County.
Impacts: Not funding this position will eliminate key educational efforts aimed at substance abuse
prevention.
Costs (Current Fiscal Year / Ongoing or Subsequent Fiscal Years): Costs for FY 2024 are
projected to be $145,000 which covers salary and fringe, plus administration and operating costs for this
prevention work.
Recommendation: I recommend the BOCC approve this cooperation agreement with the Opioid Region 3
Council.
Support Recommendation Schedule
Place on BOCC Agenda Work Session Other/Comments:
Perry L. Buck
Mike Freeman
Scott K. James
Kevin D. Ross
Lori Saine
I/l—1
as
mr
2024-0123
Ht -0057
COOPERATION AGREEMENT FOR PAYMENT OF OPIOID SETTLEMENT FUNDS
THIS COOPERATION AGREEMENT is made and entered into effective as of the date
set forth below, between the WELD OPIOID REGIONAL COUNCIL, a Regional Council
created by and through the agreements mentioned below for the purposes set forth therein, whose
address is 1 150 O Street, Greeley, CO 80631, hereinafter referred to as "Regional Council," and
Weld County Government on behalf of the Weld County Department of Public Health and
Environment whose address is 1555 North 17"' Avenue, Greeley, CO 80631, hereinafter referred
to as "Recipient."
WITNESSETH:
WHEREAS, the Regional Council oversees the procedures by which the Weld Region
may request Opioid Funds from the Colorado Opioid Abatement Council (COAC) and the
procedures by which the allocation of the Weld Region's Share of Opioid Funds (the
"Allocation") are administered, and
WHEREAS, the Regional Council has made the following Allocation to Recipient, as
detailed in the "Weld Region 3 Opioid Council — Funding Distribution," for the current year:
5145,000 for the Approved Purpose(s) detailed in Exhibit B, Statement of Work (the
"Distribution"), and in accordance with the annual budget that is developed, submitted and
approved by the Opioid Regional Council and COAC, and
WHEREAS, this Cooperation Agreement details the timing of the Distribution, and the
terms and conditions the Recipient must meet to receive the Distribution, and
WHEREAS, the Recipient agrees to comply with the terms and conditions of the
Distribution detailed herein.
WITNESSETH:
NOW, THEREFORE, in consideration of the mutual promises and covenants contained
herein, the parties hereto agree as follows:
1. Distribution of Allocation by the Regional Council. The Regional Council will release
and disburse settlement funds bi-annually (e.g. March and September); and, at a timeline
that is established by the Council. A one-time funding disbursement option may also be
available (e.g. for organizations who simply need a "one-time purchase" of equipment or
service). The Distribution is made pursuant to the following terms and conditions:
a. The Distribution is an "Approved Purpose," as defined in paragraph A.1. of the
Colorado Opioids Settlement Memorandum of Understanding, dated August 26,
2021, and as further detailed in Exhibit "A-Opioid Abatement Approved Purposes"
attached thereto. Recipient agrees not to spend any part of the Distribution on
anything other than the Approved Purpose described above.
b. The Recipient shall report to the Regional Council all expenditures of the Distribution
on forms or in the manner directed by the Regional Council.
Page 1 of 2
,zoo? a /.23
2. Term. The term of this COOPERATION AGREEMENT shall be from January 1, 2024 to
December 31, 2024. The COOPERATION AGREEMENT may be terminated if, after
notice of breach by the Regional Council to the Recipient, such breach is not cured by the
Recipient within ten (10) calendar days after the Recipient's receipt of notice. Upon such
termination, any part of the Distribution then unspent shall be returned forthwith by the
Recipient to the Regional Council.
3. Promise by the Recipient to Comply with Terms and Conditions of Distribution. The
Recipient promises to strictly comply with the terms and conditions of the Distribution
set forth in Paragraphs l.a. and l.b., above. Noncompliance with such terms and
condition may result in termination of this COOPERATION AGREEMENT and return to
the Regional Council of any unspent portion of the Distribution to the Regional Council.
4. Entire Agreement. This writing constitutes the entire agreement between the parties
hereto with respect to the subject matter herein, and shall be binding upon said parties,
their officers, employees, agents and assigns and shall inure to the benefit of the
respective survivors, heirs, personal representatives, successors and assigns of said
parties.
5. No Waiver of Immunity. No portion of this Cooperation Agreement shall be deemed to
constitute a waiver of any immunities the parties or their officers or employees may
possess, nor shall any portion of this Cooperation Agreement be deemed to have created
a duty of care which did not previously exist with respect to any person not a party to this
Cooperation Agreement.
6. No Third -Party Beneficiary Enforcement. It is expressly understood and agreed that the
enforcement of the terms and conditions of this Cooperation Agreement, and all rights of
action relating to such enforcement, shall be strictly reserved to the undersigned parties
and nothing in this Cooperation Agreement shall give or allow any claim or right of
action whatsoever by any other person not included in this Cooperation Agreement. It is
the express intention of the undersigned parties that any entity other than the undersigned
parties receiving services or benefits under this Cooperation Agreement shall be an
incidental beneficiary only.
Signed by the parties, as dated below.
RECIPIENT: Weld County Government on Behalf of the Weld County Department of
Public Health & Environment
K'evuz b. Rosy
By:
Kevin D. Ross (Jan 22, 2024 14:19 MST)
Date: Jan 22, 2024
Kevin Ross, Chair, Weld County Board of County Commissioners
WELD OPIOID REGIONAL COUNCIL:
PIC Aakko
By: Eric Aakko (Jan 22, 202413:43 MST)
Eric Aakko, Chair
Date: Jan 22, 2024
Page 2 of 2
020°21/-,0/02-3
Exhibit A
POTENTIAL OPIOID ABATEMENT APPROVED PURPOSES
I. TREATMENT
A. TREATMENT OF OPIOID USE DISORDER AND ITS EFFECTS
1. Expand availability of treatment, including Medication -Assisted Treatment
(MAT), for Opioid Use Disorder (OUD) and any co-occurring substance use or
mental health issues.
2. Supportive housing, all forms of FDA -approved MAT, counseling, peer -support,
recovery case management and residential treatment with access to medications
for those who need it.
3. Treatment of mental health trauma issues that resulted from the traumatic
experiences of the opioid user (e.g., violence, sexual assault, human trafficking)
and for family members (e.g., surviving family members after an overdose or
overdose fatality).
4. Expand telehealth to increase access to OUD treatment, including MAT, as well
as counseling, psychiatric support, and other treatment and recovery support
services.
5. Fellowships for addiction medicine specialists for direct patient care, instructors,
and clinical research for treatments.
6. Scholarships for certified addiction counselors.
7. Clinicians to obtain training and a waiver under the federal Drug Addiction
Treatment Act to prescribe MAT for OUD.
8. Training for health care providers, students, and other supporting professionals,
such as peer recovery coaches/recovery outreach specialists, including but not
limited to training relating to MAT and harm reduction.
9. Dissemination of accredited web -based training curricula, such as the American
Academy of Addiction Psychiatry's Provider Clinical Support Service-Opioids
web -based training curriculum and motivational interviewing.
10. Development and dissemination of new accredited curricula, such as the
American Academy of Addiction Psychiatry's Provider Clinical Support Service
Medication -Assisted Treatment.
11. Development of a multistate/nationally accessible database whereby health care
providers can list currently available in -patient and out -patient OUD treatment
services that are accessible on a real-time basis.
EXHIBIT A
12. Support and reimburse services that include the full American Society of
Addiction Medicine (ASAM) continuum of care for OUD.
13. Improve oversight of Opioid Treatment Programs (OTPs) to assure evidence -
informed practices such as adequate methadone dosing.
B. INTERVENTION
1. Ensure that health care providers are screening for OUD and other risk factors and
know how to appropriately counsel and treat (or refer, if necessary) a patient for
OUD treatment.
2. Fund Screening, Brief Intervention and Referral to Treatment (SBIRT) programs
to reduce the transition from use to disorder.
3. Training and long-term implementation of SBIRT in key systems (health, schools,
colleges, criminal justice, and probation), with a focus on the late adolescence and
young adulthood when transition from misuse to opioid disorder is most common.
4. Purchase automated versions of SBIRT and support ongoing costs of the
technology.
5. Training for emergency room personnel treating opioid overdose patients on post -
discharge planning, including community referrals for MAT, recovery case
management and/or support services.
6. Support work of Emergency Medical Systems, including peer support specialists,
to connect individuals to treatment or other appropriate services following an
opioid overdose or other opioid-related adverse event.
7 Create school -based contacts whom parents can engage to seek immediate
treatment services for their child.
8. Develop best practices on addressing OUD in the workplace.
9. Support assistance programs for health care providers with OUD.
10. Engage non -profits and faith community as a system to support outreach for
treatment.
C. CRIMINAL -JUSTICE -INVOLVED PERSONS
1. Address the needs of persons involved in the criminal justice system who have
OUD and any co-occurring substance use disorders or mental health (SUD/MH)
issues.
EXHIBIT A
2. Support pre -arrest diversion and deflection strategies for persons with OUD and
any co-occurring SUD/MH issues, including established strategies such as:
a. Self -referral strategies such as Angel Programs or the Police Assisted
Addiction Recovery Initiative (PAARI);
b. Active outreach strategies such as the Drug Abuse Response Team
(DART) model;
c. "Naloxone Plus" strategies, which work to ensure that individuals who
have received Naloxone to reverse the effects of an overdose are then
linked to treatment programs;
d. Officer prevention strategies, such as the Law Enforcement Assisted
Diversion (LEAD) model; or
e. Officer intervention strategies such as the Leon County, Florida Adult
Civil Citation Network.
3. Support pre-trial services that connect individuals with OUD and any co-
occurring SUD/MH issues to evidence -informed treatment, including MAT, and
related services.
4. Support treatment and recovery courts for persons with OUD and any co-
occurring SUD/MH issues, but only if they provide referrals to evidence -informed
treatment, including MAT.
5. Provide evidence -informed treatment, including MAT, recovery support, harm
reduction, or other appropriate services to individuals with OUD and any co-
occurring SUD/MH issues who are incarcerated, on probation, or on parole.
6. Provide evidence -informed treatment, including MAT, recovery support, harm
reduction, or other appropriate re-entry services to individuals with OUD and any
co-occurring SUD/MH issues who are leaving jail or prison or who have recently
left jail or prison.
7. Support critical time interventions (CTI), particularly for individuals living with
dual -diagnosis OUD/serious mental illness, and services for individuals who face
immediate risks and service needs and risks upon release from correctional
settings.
D. WOMEN WHO ARE OR MAY BECOME PREGNANT
1. Evidence -informed treatment, including MAT, recovery, and prevention services
for pregnant women or women who could become pregnant and have OUD.
2. Training for obstetricians and other healthcare personnel that work with pregnant
women and their families regarding OUD treatment.
EXHIBIT A
3. Other measures to address Neonatal Abstinence Syndrome, including prevention,
care for addiction and education programs.
4. Child and family supports for parenting women with OUD.
5. Enhanced family supports and child care services for parents receiving treatment
for OUD.
E. PEOPLE IN TREATMENT AND RECOVERY
1. The full continuum of care of recovery services for OUD and any co-occurring
substance use or mental health issues, including supportive housing, residential
treatment, medical detox services, peer support services and counseling,
community navigators, case management, and connections to community -based
services.
2. Identifying successful recovery programs such as physician, pilot, and college
recovery programs, and providing support and technical assistance to increase the
number and capacity of high -quality programs to help those in recovery.
3. Training and development of procedures for government staff to appropriately
interact and provide social and other services to current and recovering opioid
users, including reducing stigma.
4. Community -wide stigma reduction regarding treatment and support for persons
with OUD, including reducing the stigma on effective treatment.
5. Engaging non -profits and faith community as a system to support family members
in their efforts to help the opioid user in the family.
II. PREVENTION
F. PRESCRIBING PRACTICES
1. Training for health care providers regarding safe and responsible opioid
prescribing, dosing, and tapering patients off opioids.
2. Academic counter -detailing.
3. Continuing Medical Education (CME) on prescribing of opioids.
4. Support for non-opioid pain treatment alternatives, including training providers to
offer or refer to multi -modal, evidence -informed treatment of pain.
5. Fund development of a multistate/national prescription drug monitoring program
(PDMP) that permits information sharing while providing appropriate safeguards
on sharing of private information, including but not limited to:
EXHIBIT A
a. Integration of PDMP data with electronic health records, overdose
episodes, and decision support tools for health care providers relating to
OUD.
b. Ensuring PDMPs incorporate available overdose/naloxone deployment
data, including the United States Department of Transportation's
Emergency Medical Technician overdose database.
6. Educating dispensers on appropriate opioid dispensing.
G. MISUSE OF OPIOIDS
1. Corrective advertising/affirmative public education campaigns.
2. Public education relating to drug disposal.
3. Drug take -back disposal or destruction programs.
4. Fund community anti -drug coalitions that engage in drug -abuse prevention
efforts.
5. School -based programs that have demonstrated effectiveness in preventing drug
misuse and seem likely to be effective in preventing the uptake and use of
opioids.
6. Support community coalitions in implementing evidence -informed prevention,
such as reduced social access and physical access, stigma reduction — including
staffing, educational campaigns, or training of coalitions in evidence -informed
implementation.
7. School and community education programs and campaigns for students, families,
school employees, school athletic programs, parent -teacher and student
associations, and others.
8. Engaging non -profits and faith community as a system to support prevention.
H. OVERDOSE DEATHS AND OTHER HARMS
1. Increasing availability and distribution of naloxone and other drugs that treat
overdoses to first responders, overdose patients, opioid users, families and friends
of opioid users, schools, community navigators and outreach workers, drug
offenders upon release from jail/prison, and other members of the general public.
2. Training and education regarding naloxone and other drugs that treat overdoses
for first responders, overdose patients, patients taking opioids, families, schools,
and other members of the general public.
EXHIBIT A
3. Developing data tracking software and applications for overdoses/naloxone
revivals.
4. Public education relating to emergency responses to overdoses.
5. Free naloxone for anyone in the community.
6. Public education relating to immunity and Good Samaritan laws.
7. Educating first responders regarding the existence and operation of immunity and
Good Samaritan laws.
8. Syringe service programs, including supplies, staffing, space, peer support
services, and the full range of harm reduction and treatment services provided by
these programs.
9. Expand access to testing and treatment for infectious diseases such as HIV and
Hepatitis C resulting from intravenous opioid use.
III. ADDITIONAL AREAS
I. SERVICES FOR CHILDREN
1. Support for children's services: Fund additional positions and services, including
supportive housing and other residential services, relating to children being
removed from the home and/or placed in foster care due to custodial opioid use.
J. FIRST RESPONDERS
1. Law enforcement expenditures relating to the opioid epidemic.
2. Educating first responders regarding appropriate practices and precautions when
dealing with fentanyl or other drugs.
3. Increase electronic prescribing to prevent diversion and forgery.
K. COMMUNITY LEADERSHIP
1. Regional planning to identify goals for opioid reduction and support efforts or to
identify areas and populations with the greatest needs for treatment intervention
services.
2. Government dashboard to track key opioid-related indicators and supports as
identified through collaborative community processes.
EXHIBIT A
L. STAFFING AND TRAINING
1. Funding for programs and services regarding staff training and networking to
improve staff capability to abate the opioid crisis.
2. Support infrastructure and staffing for collaborative cross -systems coordination to
prevent opioid misuse, prevent overdoses, and treat those with OUD (e.g., health
care, primary care, pharmacies, PDMPs, etc.).
M. RESEARCH
1. Funding opioid abatement research.
2. Research improved service delivery for modalities such as SBIRT that
demonstrate promising but mixed results in populations vulnerable to OUD.
3. Support research for novel harm reduction and prevention efforts such as the
provision of fentanyl test strips.
4. Support for innovative supply-side enforcement efforts such as improved
detection of mail -based delivery of synthetic opioids.
5. Expanded research for swift/certain/fair models to reduce and deter opioid misuse
within criminal justice populations that build upon promising approaches used to
address other substances (e.g. Hawaii HOPE and Dakota 24/7).
6. Research expanded modalities such as prescription methadone that can expand
access to MAT.
N. OTHER
1. Administrative costs for any of the approved purposes on this list.
EXHIBIT A
EXHIBIT B
STATEMENT OF WORK
To Cooperation Agreement for Payment of Opioid Settlement Funds
These provisions are to be read and interpreted in conjunction with the provisions of the agreement specified above.
I. Entity (Recipient) Name: Weld County Government on behalf of the Weld County Department of Public
Health and Environment
II. Term: January 1, 2024 — December 31, 2024
III. Recipient's Total Allocation for ALL Approved Uses: $145,000
IV. Project Description: Weld Region 3 Opioid Abatement Council Administration & Distribution of Weld's Regional
Share of National Opioid Settlement Funds
V. Approved Purposes: can be found at https://coag.gov/app/uploads/2022/07/CO-MOU-Exhibit-A.pdf
VI. Definitions:
COAC — Colorado Opioid Abatement Council
WR3 — Weld Opioid Regional Council, Region 3
Allocation — Recipient's share of opioid funds
Recipient — Agency receiving funding
VII. Work Plan:
Approved Purpose #1: II. Prevention. G. Misuse of Opioids. 6. Support community coalitions in
implementing evidence -informed prevention, such as reduced social access and physical access, stigma
reduction — including staffing, educational campaigns, or training of coalitions in evidence -informed
implementation. 7. School and community education programs and campaigns for students, families,
school employees, school athletic programs, parent -teacher and student associations, and others.
Primary Activity #1
and Budgeted
Allocation
Recipient shall employ 1.0 FTE Substance Use Disorder Prevention Specialist to provide
evidence -informed substance use education and prevention programs for students, families,
school employees, organizations, communtiy groups/coalitions.. They shall select or develop
Substance Use Disorder prevention activities or programs that address public health objectives
using evidence -informed strategies.
Council approved budget: $102,000
Primary Activity #2
and Budgeted
Allocation
Recipient shall plan a countywide media campaign to address the stigma around opioid use
disorder. The media campaign shall be planned in accordance with key informant interviews of
16 key partners and community members in the Weld County substance use prevention realm;
these partners identified stigma, prevention, and community outreach as a key role for
WCDPHE to fill.
Council approved budget: $18,000
Approved Purpose #2: III. Additional Areas. N. Other. 1. Administrative costs for any of the approved
purposes on the list.
Primary Activity #1
and Budgeted
Allocation
Recipient shall provide funding for the Fiscal Agent for Weld Region 3.
Council approved budget: $20,000
Page 1 of 2
EXHIBIT B
Primary Activity #2
and Budgeted
Allocation
Recipient shall provide funding for the Chair who will provide oversight of the Weld (Region
3) Opioid Abatement Council and collaborate with various partners and community groups to
ensure the success of the Weld Opioid Abatement Council deliverables and sustaining activies
to meet program goals.
Council approved budget: $5,000
Expected Results of
ACtivity(S)
Activity 1 - The Substance Use Disorder Prevention Specialist shall provide eight (or more)
substance use prevention-educuation programs yearly.
Activity 2 - The Substance Use Disorder Prevention Specialist shall facilitate four quarterly
Weld Opioid Council meetings a year.
Activity 3 - The Weld County anti -stigma media campaign shall reach a large and diverse
number of Weld County residents to change perceptions (stigma) around substance use.
Measurement of
Expected Results
Activity 1 - Type of education and/or prevention program, number of participants, pre/post
surveys to evaluate change in perceptions.
Activity 2 - Weld County Opioid Abatement Council meeting agenda's and meeting minutes.
Activity 3 - Number of website engagements, # of pledges to end stigma.
I�rr'4��J„Jt � f f•'�`i'i NF�N�riff r�SJ �f iF � J / f r /�'r fw 'J•,/r''rl. rEi� fJ`/1.'
' ,� % s/fs Js f f jr�i" , f , ,f 1, �s J, J/ fir ., ///tf'1/ 0,, r, ,+ fJ ,
F! !/�fjf � JJFf f �f�i�/ 14' !.7 j%i3rf ��k �J/f�if�Fl %%'1/"rr fiflfJ�I,�ffi1 '��fr� Tl�jL
',/, � -'.iff.Ffff3f .f�lFf ; ft� i3 i �f,�3 .� t f �f :�;1X �!�1� Si i3 f'i�J/�,Ffi{y1f :�F.•�ff ;�� ��ffl f/Sf� . F�r 'Nf;:� t
Completion
p
Date
Deliverables
1. The Recipient shall submit electronically to the Chair and Fiscal
Agent semi-annual distribution requests and financial information
documenting the expenditures and outcomes related to the
distrubtion requests.
No later than
January 15 and July
15 of each funding
period.
2. The Recipient shall submit electronically to the Chair an annual
report, or other periodic reports, as required by the COAC.
No later than fifteen
(15) days following
the end of funding
term or thirty (30)
days following
request by Chair for
unanticipated
periodic reports.
Page 2 of 2
ontract For
Entity Information
Entity Name* Entity ID*
WELD OPIOID REGIONAL COUNCIL @00047970
Contract Name *
OPIOID COUNCIL COOPERATION AGREEMENT
FUNDING FOR SUBSTANCE USE PREVENTION
Contract Status
CTB REVIEW
Q New Entity?
Contract ID
7742
Contract Lead *
BFRITZ
Contract Lead Email
bfritz@weld.gov;Health-
Contracts@weld.gov
Parent Contract ID
Requires Board Approval
YES
Department Project #
Contract Description *
OPIOID COUNCIL COOPERATION AGREEMENT FUNDING FOR SUBSTANCE USE PREVENTION
Contract Description 2
Contract Type*
AGREEMENT
Amount*
$145,000.00
Renewable *
NO
Automatic Renewal
NO
Grant
NO
IGA
NO
Department
HEALTH
Department Email
CM-Health@weldgov.com
Department Head Email
CM-Health-
DeptHead@weldgov.com
County Attorney
GENERAL COUNTY
ATTORNEY EMAIL
County Attorney Email
CM-
COUNTYATTORNEY@WEL
DGOV.COM
If this is a renewal enter previous Contract ID
If this is part of a MSA enter MSA Contract ID
Requested BOCC Agenda Due Date
Date* 01 /06/2024
01/10/2024
Will a work session with BOCC be required?*
NO
Does Contract require Purchasing Dept. to be
included?
NO
Note: the Previous Contract Number and Master Services Agreement Number should be left blank if those contracts
are not in OnBase
Contract Dates
Effective Date
01/01/2024
Review Date *
10/01/2024
Termination Notice Period Committed Delivery Date
Contact Information
Contact Info
Renewal Date
Expiration Date*
12/31/2024
Contact Name Contact Type Contact Email Contact Phone 1 Contact Phone 2
Purchasing
Purchasing Approver Purchasing Approved Date
Approval Process
Department Head
JASON CHESSHER
DH Approved Date
01/09/2024
Final Approval
BOCC Approved
BOCC Signed Date
BOCC Agenda Date
01/17/2024
Finance Approver
CHRIS D'OVIDIO
Legal Counsel
BYRON HOWELL
Finance Approved Date Legal Counsel Approved Date
01/09/2024 01/09/2024
Tyler Ref #
AG 011724
Originator
BFRITZ
Hello